Cargando…
Discovery of Triazolo-pyridazine/-pyrimidine Derivatives Bearing Aromatic (Heterocycle)-Coupled Azole Units as Class II c-Met Inhibitors
[Image: see text] Two series of novel triazolo-pyridazine/-pyrimidine derivatives were designed, synthesized, and evaluated for their inhibitory activity against c-Met kinase, as well as three c-Met overexpressed cancer cell lines (A549, MCF-7, and HeLa) and one normal human hepatocytes cell line LO...
Autores principales: | Zhang, Qian, Liu, Xiaobo, Gan, Wenhui, Wu, Jinjin, Zhou, Hualan, Yang, Zunhua, Zhang, Yiling, Liao, Min, Yuan, Ping, Xu, Shan, Zheng, Pengwu, Zhu, Wufu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364574/ https://www.ncbi.nlm.nih.gov/pubmed/32685812 http://dx.doi.org/10.1021/acsomega.0c00838 |
Ejemplares similares
-
Design, Synthesis, and Biological Evaluation of [1,2,4]triazolo[4,3-a] Pyrazine Derivatives as Novel Dual c-Met/VEGFR-2 Inhibitors
por: Liu, Xiaobo, et al.
Publicado: (2022) -
Synthesis and Biological Evaluation of Novel 4-Morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine Derivatives Bearing Phenylpyridine/ Phenylpyrimidine-Carboxamides
por: Liu, Huimin, et al.
Publicado: (2016) -
Design, Synthesis and Biological Evaluation of 6,7-Disubstituted-4-phenoxyquinoline Derivatives Bearing Pyridazinone Moiety as c-Met Inhibitors
por: Liu, Xiaobo, et al.
Publicado: (2018) -
Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors
por: Tu, Yuanbiao, et al.
Publicado: (2018) -
Research Progress of Small Molecule VEGFR/c-Met Inhibitors as Anticancer Agents (2016–Present)
por: Zhang, Qian, et al.
Publicado: (2020)